{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:02:57Z","timestamp":1758816177180,"version":"3.41.2"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/igc.0b013e31822265ad","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T14:29:57Z","timestamp":1309444197000},"page":"1606-1612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stage III Uterine Carcinosarcoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Gunjal","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"Deppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene P.","family":"Toy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31822265ad_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"unstructured":"Surveillance Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.","key":"10.1097\/IGC.0b013e31822265ad_bb0010"},{"key":"10.1097\/IGC.0b013e31822265ad_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.2002.6713","article-title":"Assessment of prognostic factors in stage IIIA endometrial cancer","volume":"86","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0020","first-page":"175","article-title":"Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium","volume":"74","author":"Lurain","year":"1989","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(92)90246-F","article-title":"Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease","volume":"46","author":"Kadar","year":"1992","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-9098(199706)65:2<82::AID-JSO3>3.0.CO;2-J","article-title":"A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma","volume":"65","author":"Hirahatake","year":"1997","journal-title":"J Surg Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.2001.6157","article-title":"Analysis of FIGO Stage IIIC endometrial cancer patients","volume":"81","author":"McMeekin","year":"2001","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/gyno.2002.6789","article-title":"Stage IIIC endometrioid corpus cancer includes distinct subgroups","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: a debated clinical challenge","volume":"65","author":"Gadducci","year":"2008","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2008.05.016","article-title":"Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis","volume":"111","author":"Nemani","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0065","first-page":"1702","article-title":"Prognostic factors in early-stage uterine sarcoma","volume":"71","author":"Major","year":"1993","journal-title":"A Gynecologic Oncology Group study. Cancer."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/IGC.0b013e3181dc8292","article-title":"Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes","volume":"20","author":"Garg","year":"2010","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/gyno.1997.4901","article-title":"The impact of adjuvant radiotherapy on carcinosarcoma of the uterus","volume":"68","author":"Gerszten","year":"1998","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1200\/JCO.2006.06.4907","article-title":"Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study","volume":"25","author":"Homesley","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.07.070","article-title":"A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus","volume":"107","author":"Wolfson","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.2000.6001","article-title":"A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study","volume":"79","author":"Sutton","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0095","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1200\/JCO.2009.26.8326","article-title":"Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"28","author":"Powell","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0100","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1097-0142(20000615)88:12<2782::AID-CNCR17>3.0.CO;2-K","article-title":"Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus","volume":"88","author":"Yamada","year":"2000","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/gyno.1997.4827","article-title":"Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study","volume":"67","author":"Sartori","year":"1997","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0110","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.2010.31.2124","article-title":"Influence of gynecologic oncologists on the survival of patients with endometrial cancer","volume":"29","author":"Chan","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31822265ad_bb0115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.22561","article-title":"Centralization of care for patients with advanced stage ovarian cancer: a cost effectiveness analysis","volume":"109","author":"RE","year":"2007","journal-title":"Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2408928X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2408928X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31822265ad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:08:33Z","timestamp":1753232913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2408928X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1048891X2408928X"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31822265ad","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stage III Uterine Carcinosarcoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31822265ad","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}